[1]栾玉玲,张凌霄,邢丽娜,等.心脏类器官的构建及应用[J].国际心血管病杂志,2023,06:350-353.
点击复制
心脏类器官的构建及应用(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2023年06期
- 页码:
- 350-353
- 栏目:
- 综述
- 出版日期:
- 2023-11-20
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2023.06.004
- 文献标识码:
- -
- 摘要:
- 心脏类器官可在体外精确模拟机体的病理生理改变，弥补细胞模型与动物实验 无法准确模拟机体代谢的不足，在疾病机制探索与药物开发方面有广泛的应用优势与前景。 该文主要介绍心脏类器官的构建方法和应用及其优势和面临的挑战，为心脏类器官在生物医 学和疾病治疗领域的研究提供新的思路。
- Abstract:
- -
参考文献/References
[1] Rossi G, Manfrin A, Lutolf MP. Progress and potential in
organoid research[J]. Nat Rev Genet, 2018, 19(11):671-687.
[2] Corrò C. Novellasdemunt L, Li VSW. A brief history
of organoids[J]. Am J Physiol Cell Physiol, 2020,
319(1):C151-C165.
[3] Lehmann R, Lee CM, Shugart EC, et al. Human organoids:
a new dimension in cell biology[J]. Mol Biol Cell, 2019,
30(10):1129-1137.
[4] Mollica PA, Booth-Creech EN, Reid JA, et al. 3D bioprinted
mammary organoids and tumoroids in human mammary
derived ECM hydrogels[J]. Acta Biomater, 2019, 95:201-213.
[5] Liu HT, Wang YQ, Cui KL, et al. Advances in hydrogels in
organoids and organs-on-a-chip[J]. Advanced Materials, 2019,
31(50):e1902042.
[6] Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue
engineering: state of the art[J]. Circ Res, 2014, 114(2):354-
367.
[7] Weinberger F, Mannhardt I, Eschenhagen T. Engineering
cardiac muscle tissue: a maturating field of research[J]. Circ
Res, 2017, 120(9):1487-1500.
[8] Wei Z, Schnellmann R, Pruitt HC, et al. Hydrogel network
dynamics regulate vascular morphogenesis[J]. Cell Stem Cell,
2020, 27(5):798-812.
[9] Shkumatov A, Baek K, Kong H. Matrix rigidity-modulated
cardiovascular organoid formation from embryoid bodies[J].
PLoS One, 2014, 9(4):e94764.
[10] Ahadian S, Yamada S, Ramón-Azcón J, et al. Hybrid
hydrogel-aligned carbon nanotube scaffolds to enhance cardiac
differentiation of embryoid bodies[J]. Acta Biomater, 2016,
31:134-143.
[11] Astashkina AI, Mann BK, Prestwich GD, et al. A 3-D
organoid kidney culture model engineered for high-throughput
nephrotoxicity assays[J]. Biomaterials, 2012, 33(18):4700-
4711.
[12] Yi SA, Zhang YX, Rathnam C, et al. Bioengineering
approaches for the advanced organoid research[J]. Adv Mater,
2021, 33(45):e2007949.
[13] Wu FX, Gao AJ, Liu J, et al. High modulus conductive
hydrogels enhance in vitro maturation and contractile function
of primary cardiomyocytes for uses in drug screening[J]. Adv
Healthc Mater, 2018, 7(24):e1800990.
[14] Noor N, Shapira A, Edri R, et al. 3D printing of personalized
thick and perfusable cardiac patches and hearts[J]. Adv Sci(Weinh), 2019, 6(11):1900344.
[15] Lee A, Hudson AR, Shiwarski DJ, et al. 3D bioprinting of
collagen to rebuild components of the human heart[J]. Science,
2019, 365(6452):482-487.
[16] Zhang F, Qu KY, Zhou B, et al. Design and fabrication of an
integrated heart-on-a-chip platform for construction of cardiac
tissue from human iPSC-derived cardiomyocytes and in situ
evaluation of physiological function[J]. Biosens Bioelectron,
2021, 179:113080.
[17] Ugolini GS, Visone R, Cruz-Moreira D, et al. Generation of
functional cardiac microtissues in a beating heart-on-a-chip[J].
Methods Cell Biol, 2018, 146:69-84.
[18] Cho KW, Lee WH, Kim BS, et al. Sensors in heart-on-a-chip:
a review on recent progress[J]. Talanta, 2020, 219:121269.
[19] Grosberg A, Alford PW, McCain ML, et al. Ensembles
of engineered cardiac tissues for physiological and
pharmacological study: heart on a chip[J]. Lab Chip, 2011,
11(24):4165-4173.
[20] Jayne RK, Karakan M?, Zhang KH, et al. Direct laser writing
for cardiac tissue engineering: a microfluidic heart on a chip
with integrated transducers[J]. Lab Chip, 2021, 21(9):1724-
1737.
[21] Luni C, Gagliano O, Elvassore N. Derivation and
differentiation of human pluripotent stem cells in microfluidic
devices[J]. Annu Rev Biomed Eng, 2022, 24:231-248.
[22] Fu F, Chen Z, Zhao Z, et al. Bio-inspired self-healing
structural color hydrogel[J]. Proc Natl Acad Sci U S A, 2017,
114(23):5900-5905.
[23] Sun L, Chen Z, Xu D, et al. Electroconductive and anisotropic
structural color hydrogels for visual heart-on-a-chip
construction[J]. Adv Sci (Weinh), 2022, 9(16):e2105777.
[24] Shang YX, Chen ZY, Fu FF, et al. Cardiomyocyte-Driven
structural color actuation in anisotropic inverse opals[J]. ACS
Nano, 2019, 13(1):796-802.
[25] Shinnawi R, Shaheen N, Huber I, et al. Modeling reentry in
the short QT syndrome with human-induced pluripotent stem
cell-derived cardiac cell sheets[J]. J Am Coll Cardiol, 2019,
73(18):2310-2324.
[26] Hofbauer P, Jahnel SM, Papai N, et al. Cardioids reveal selforganizing
principles of human cardiogenesis[J]. Cell, 2021,
184(12):3299-3317.e22.
[27] Bleijs M, van de Wetering M, Clevers H, et al. Xenograft and
organoid model systems in cancer research[J]. EMBO J, 2019,
38(15):e101654.
[28] Mills RJ, Parker BL, Quaife-Ryan GA, et al. Drug screening
in human PSC-Cardiac organoids identifies pro-proliferative
compounds acting via the mevalonate pathway[J]. Cell Stem
Cell, 2019, 24(6):895-907.
[29] Lemme M, Ulmer BM, Lemoine MD, et al. Atrial-like
engineered heart tissue: an in vitro model of the human
atrium[J]. Stem Cell Reports, 2018, 11(6):1378-1390.
[30] Takeda M, Miyagawa S, Fukushima S, et al. Development
of in vitro drug-induced cardiotoxicity assay by using threedimensional
cardiac tissues derived from human induced
pluripotent stem cells[J]. Tissue Eng Part C Methods, 2018,
24(1):56-67.
[31] 范斯文, 赵玉涵, 肖光旭, 等. 3D类器官心脏肥大模型的建
立及在心血管病治疗中药作用机制解析中的应用[J]. 药学
学报, 2022, 57(10):3067-3076.
[32] Wang TY, Chen XN, Yu JH, et al. High-throughput
electrophysiology screen revealed cardiotoxicity of strychnine
by selectively targeting hERG Channel[J]. Am J Chin Med,
2018, 46(8):1825-1840.
[33] Becker N, Stoelzle S, G?pel S, et al. Minimized cell usage
for stem cell-derived and primary cells on an automated
patch clamp system[J]. J Pharmacol Toxicol Methods, 2013,
68(1):82-87.
备注/Memo
- 备注/Memo:
-
基金项目：上海市“科技创新行动计划”医学创新研究专项
(21Y11909600) ；上海市普陀区卫生健康系统临床医学学科项目
（2023ysxk01）
通信作者：刘宗军， E-mail：lzj72@126.com
常用功能
统计/Statistics
- 摘要浏览/Viewed3
- 全文下载/Downloads248
- 评论/Comments
